Navamedic ASA: Mandatory notice of trade Publisert: 11.07.2025 Navamedic ASA: Updated key information relating to the rights issue Publisert: 10.07.2025 Navamedic ASA – Additional underwriting commitments in the Rights Issue Publisert: 29.06.2025 Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product Publisert: 27.06.2025 Navamedic ASA – Investor presentation regarding the acquisition of the business of dne pharma AS Publisert: 24.06.2025 Navamedic ASA: Mandatory notice of trade Publisert: 23.06.2025 FørsteForrige89101112NesteSiste
Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product Publisert: 27.06.2025
Navamedic ASA – Investor presentation regarding the acquisition of the business of dne pharma AS Publisert: 24.06.2025